A. O. Smith Corporation 831865209 04/13/2026 Proposal to approve, by nonbinding advisory vote, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1989.0 0.0 AGAINST 1989.0 AGAINST Accenture plc G1151C101 01/28/2026 To approve, in a non-binding vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10543.0 0.0 AGAINST 10543.0 AGAINST Align Technology, Inc. 016255101 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 83428.0 0.0 AGAINST 83428.0 AGAINST Alkermes plc G01767105 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 250000.0 0.0 AGAINST 250000.0 AGAINST Amazon.com, Inc. 023135106 05/20/2026 Advisory Vote To Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 971683.0 0.0 FOR 971683.0 FOR Aon plc G0403H108 06/26/2026 Advisory resolution to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 298059.0 0.0 AGAINST 298059.0 AGAINST Arthur J. Gallagher & Co. 363576109 05/12/2026 Approval, on an advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3381.0 0.0 AGAINST 3381.0 AGAINST Automatic Data Processing, Inc. 053015103 11/12/2025 Advisory Vote on Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2990.0 0.0 AGAINST 2990.0 AGAINST BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 267851.0 0.0 AGAINST 267851.0 AGAINST BJ's Wholesale Club Holdings, Inc. 05550J101 06/18/2026 Approve, on an advisory (non-binding) basis, the compensation of the named executive officers of BJ's Wholesale Club Holdings, Inc. SECTION 14A SAY-ON-PAY VOTES ISSUER 1449.0 0.0 AGAINST 1449.0 AGAINST BJ's Wholesale Club Holdings, Inc. 05550J101 06/18/2026 Approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of the named executive officers of BJ's Wholesale Club Holdings, Inc. SECTION 14A SAY-ON-PAY VOTES ISSUER 1449.0 0.0 1 YEAR 1449.0 FOR Boston Scientific Corporation 101137107 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 120000.0 0.0 AGAINST 120000.0 AGAINST Brown & Brown, Inc. 115236101 05/06/2026 To approve, on an advisory basis, the compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 11022.0 0.0 AGAINST 11022.0 AGAINST Cencora, Inc. 03073E105 03/05/2026 Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4715.0 0.0 AGAINST 4715.0 AGAINST Chemed Corporation 16359R103 05/18/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5117.0 0.0 AGAINST 5117.0 AGAINST Clean Harbors, Inc. 184496107 05/20/2026 To approve on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Company's definitive proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 796.0 0.0 AGAINST 796.0 AGAINST Coherus Oncology, Inc. 19249H103 05/29/2026 To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 1928464.0 0.0 AGAINST 1928464.0 AGAINST Copart, Inc. 217204106 12/05/2025 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 30347.0 0.0 AGAINST 30347.0 AGAINST DexCom, Inc. 252131107 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 484000.0 0.0 AGAINST 484000.0 AGAINST Edwards Lifesciences Corporation 28176E108 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 299836.0 0.0 AGAINST 299836.0 AGAINST Electronic Arts Inc. 285512109 08/14/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2484.0 0.0 AGAINST 2484.0 AGAINST Elevance Health, Inc. 036752103 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 65000.0 0.0 AGAINST 65000.0 AGAINST Exact Sciences Corporation 30063P105 02/20/2026 Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Exact Sciences Corporation's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 511226.0 0.0 AGAINST 511226.0 AGAINST Ferguson Enterprises Inc. 31488V107 12/03/2025 To approve, on an advisory basis, the fiscal 2025 compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 178867.0 0.0 AGAINST 178867.0 AGAINST Ferguson Enterprises Inc. US31488V1070 12/03/2025 To approve, on an advisory basis, the fiscal 2025 compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 219191.0 0.0 AGAINST 219191.0 AGAINST Ferguson Enterprises Inc. 31488V107 04/30/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers for the five-month transition period from August 1, 2025 to December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 846.0 0.0 AGAINST 846.0 AGAINST Genpact Limited G3922B107 04/23/2026 Approve, On A Non-Binding, Advisory Basis, The Compensation Of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 59508.0 0.0 AGAINST 59508.0 AGAINST Glaukos Corporation 377322102 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 207212.0 0.0 AGAINST 207212.0 AGAINST Global Payments Inc. 37940X102 04/30/2026 Approval, on an advisory basis, of the compensation of the company's named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1466.0 0.0 AGAINST 1466.0 AGAINST Insmed Incorporated 457669307 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 136110.0 0.0 AGAINST 136110.0 AGAINST Insulet Corporation 45784P101 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 99908.0 0.0 AGAINST 99908.0 AGAINST Intercontinental Exchange, Inc. 45866F104 05/15/2026 To approve, by non-binding vote, the advisory resolution on executive compensation for named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 769664.0 0.0 FOR 769664.0 FOR Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 78311.0 0.0 AGAINST 78311.0 AGAINST Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 366000.0 0.0 AGAINST 366000.0 AGAINST Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1260000.0 0.0 AGAINST 1260000.0 AGAINST Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve, by non-binding advisory vote, the frequency of future votes on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1260000.0 0.0 1 YEAR 1260000.0 FOR iRhythm Holdings, Inc. 450056106 05/27/2026 To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 80000.0 0.0 AGAINST 80000.0 AGAINST Karyopharm Therapeutics Inc. 48576U205 05/21/2026 To approve, on an advisory basis, the compensation of our named executive officers, as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 100000.0 0.0 AGAINST 100000.0 AGAINST Krystal Biotech, Inc. 501147102 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 67809.0 0.0 AGAINST 67809.0 AGAINST Linde plc G54950103 07/29/2025 To approve, on an advisory and non-binding basis, the compensation of Linde plc's Named Executive Officers, as disclosed in the 2025 Proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 602245.0 0.0 FOR 602245.0 FOR Linde plc G54950103 07/29/2025 To recommend, on an advisory and non-binding basis, the frequency of holding future advisory shareholder votes on the compensation of Linde plc's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 602245.0 0.0 1 YEAR 602245.0 FOR McKesson Corporation 58155Q103 07/30/2025 Advisory Vote to Approve the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 3536.0 0.0 AGAINST 3536.0 AGAINST Medtronic plc G5960L103 10/16/2025 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 255000.0 0.0 AGAINST 255000.0 AGAINST MercadoLibre, Inc. 58733R102 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers for fiscal year 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 37355.0 0.0 AGAINST 37355.0 AGAINST Microsoft Corporation 594918104 12/05/2025 Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote") SECTION 14A SAY-ON-PAY VOTES ISSUER 688502.0 0.0 AGAINST 688502.0 AGAINST MSCI Inc. 55354G100 04/21/2026 To approve, by advisory vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 384.0 0.0 AGAINST 384.0 AGAINST Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 138000.0 0.0 AGAINST 138000.0 AGAINST Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 138000.0 0.0 1 YEAR 138000.0 FOR Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 125000.0 0.0 AGAINST 125000.0 AGAINST NextEra Energy, Inc. 65339F101 05/21/2026 Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1779091.0 0.0 FOR 1779091.0 FOR NovoCure Limited G6674U108 06/03/2026 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 971784.0 0.0 AGAINST 971784.0 AGAINST Outset Medical, Inc. 690145206 06/04/2026 To approve, on a non-binding basis, the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 66666.0 0.0 AGAINST 66666.0 AGAINST Parker-Hannifin Corporation 701094104 10/22/2025 Approval of, on a non-binding, advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 319943.0 0.0 AGAINST 319943.0 AGAINST Penumbra, Inc. 70975L107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 72000.0 0.0 FOR 72000.0 FOR Penumbra, Inc. 70975L107 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 72000.0 0.0 AGAINST 72000.0 AGAINST Privia Health Group, Inc. 74276R102 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). SECTION 14A SAY-ON-PAY VOTES ISSUER 610000.0 0.0 AGAINST 610000.0 AGAINST PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 375000.0 0.0 AGAINST 375000.0 AGAINST PTC Inc. 69370C100 02/11/2026 Advisory vote to approve the compensation of our named executive officers (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 2278.0 0.0 AGAINST 2278.0 AGAINST Republic Services, Inc. 760759100 05/07/2026 Advisory vote to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 386300.0 0.0 FOR 386300.0 FOR ResMed Inc. 761152107 11/19/2025 Approve, on an advisory basis, the compensation pald to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1769.0 0.0 AGAINST 1769.0 AGAINST Roper Technologies, Inc. 776696106 05/19/2026 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8031.0 0.0 AGAINST 8031.0 AGAINST Royal Gold, Inc. 780287108 05/21/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 21785.0 0.0 AGAINST 21785.0 AGAINST Royalty Pharma Plc G7709Q104 06/04/2026 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 661776.0 0.0 AGAINST 661776.0 AGAINST Ryan Specialty Holdings, Inc. 78351F107 04/28/2026 To approve, by a non-binding advisory vote, the compensation of our named executive officers (i.e., "say-on-pay proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 3629.0 0.0 AGAINST 3629.0 AGAINST S&P Global Inc. 78409V104 05/20/2026 Approve, on an advisory basis, the executive compensation program for the Company's named executive officers, as described in the Proxy Statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 283290.0 0.0 FOR 283290.0 FOR Sarepta Therapeutics, Inc. 803607100 06/04/2026 Advisory vote to approve, on a non-binding basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 490329.0 0.0 AGAINST 490329.0 AGAINST Service Corporation International 817565104 05/06/2026 To approve, by advisory vote, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 12477.0 0.0 AGAINST 12477.0 AGAINST Synopsys, Inc. 871607107 04/16/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 598.0 0.0 AGAINST 598.0 AGAINST The Procter & Gamble Company 742718109 10/14/2025 Advisory Vote to Approve the Company's Executive Compensation (the "Say on Pay" vote) SECTION 14A SAY-ON-PAY VOTES ISSUER 1061301.0 0.0 AGAINST 1061301.0 AGAINST The Progressive Corporation 743315103 05/08/2026 Cast an advisory vote to approve our executive compensation program. SECTION 14A SAY-ON-PAY VOTES ISSUER 515572.0 0.0 FOR 515572.0 FOR Thermo Fisher Scientific Inc. 883556102 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 454701.0 0.0 AGAINST 454701.0 AGAINST Tradeweb Markets Inc. 892672106 05/19/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5807.0 0.0 AGAINST 5807.0 AGAINST TransUnion 89400J107 05/12/2026 To approve, on a non-binding advisory basis, the compensation of TransUnion's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2043.0 0.0 AGAINST 2043.0 AGAINST Tyler Technologies, Inc. 902252105 05/05/2026 Advisory Approval of Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 374.0 0.0 AGAINST 374.0 AGAINST Uber Technologies, Inc. 90353T100 05/04/2026 Advisory vote to approve 2025 named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1026887.0 0.0 FOR 1026887.0 FOR Uber Technologies, Inc. 90353T100 05/04/2026 Advisory vote on the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1026887.0 0.0 1 YEAR 1026887.0 FOR Vaxcyte, Inc. 92243G108 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 195000.0 0.0 AGAINST 195000.0 AGAINST Verisk Analytics, Inc. 92345Y106 05/19/2026 To approve executive compensation on an advisory, non-binding basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 663.0 0.0 AGAINST 663.0 AGAINST Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 46057.0 0.0 AGAINST 46057.0 AGAINST Visa Inc. 92826C839 01/27/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 825212.0 0.0 AGAINST 825212.0 AGAINST Waters Corporation 941848103 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 583.0 0.0 AGAINST 583.0 AGAINST Zai Lab Limited 98887Q104 06/17/2026 That, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 510000.0 0.0 AGAINST 510000.0 AGAINST